Palatin Technologies PTN
NASDAQ PTN
$12.02 -0.31 (-2.51%)
At close: Sep 10, 2026 · 4:00 PM EDT

Palatin Technologies (PTN) Cash from Operations (2010 - 2026)

Palatin Technologies' (PTN) quarterly Cash from Operations came in at -$4.4 million in Q1 2026, up 17.5% on a YoY basis from -$3.8 million in Q1 2025, and up 8.11% quarter-over-quarter from -$4.8 million in Q4 2025.

Analysis

Palatin Technologies (PTN) Cash from Operations (2010 - 2026) Analysis & Trends

Palatin Technologies (PTN) has reported Cash from Operations for 17 consecutive years, with -$4.4 million the latest figure, recorded in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Operations rose 17.5% year-over-year to -$4.4 million; the trailing twelve-month figure through Mar 2026 stood at -$14.9 million (up 36.97% YoY), and the FY2025 full-year result was -$21.3 million, up 32.28% from the prior year.
  • Cash from Operations advanced to -$4.4 million in Q1 2026 per PTN's latest filing, from -$4.8 million in the prior quarter.
  • Across five years, Cash from Operations topped out at -$1.4 million in Q1 2023 and bottomed at -$10.5 million in Q4 2023.
  • Historically, Cash from Operations has averaged -$6.5 million across 5 years, with a median of -$6.5 million in 2024.
  • The sharpest annual moves came in 2022 and 2023: Cash from Operations slumped 4140.77% in 2022, then surged 85.16% in 2023.
  • Over 5 years, Cash from Operations stood at -$9.7 million in 2022, then declined by 8.27% to -$10.5 million in 2023, then surged by 53.73% to -$4.8 million in 2024, then advanced by 0.83% to -$4.8 million in 2025, then gained by 8.11% to -$4.4 million in 2026.
  • According to Business Quant data, Cash from Operations over the past three periods registered -$4.4 million, -$4.8 million, and -$1.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 4.00 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 3.57 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 1.13 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 813.00 Mn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -526.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 326.72 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 448.90 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -270.50 Mn
10 Palatin Technologies 46.98 Mn 46.98 Mn - -4.42 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.42 Mn
Dec 31, 2025 -4.81 Mn
Sep 30, 2025 -1.62 Mn
Jun 30, 2025 -4.09 Mn
Mar 31, 2025 -5.35 Mn
Dec 31, 2024 -4.85 Mn
Sep 30, 2024 -7.02 Mn
Jun 30, 2024 -6.47 Mn
Mar 31, 2024 -8.61 Mn
Dec 31, 2023 -10.48 Mn
Sep 30, 2023 -5.91 Mn
Jun 30, 2023 -9.61 Mn
Mar 31, 2023 -1.41 Mn
Dec 31, 2022 -9.68 Mn
Sep 30, 2022 -8.58 Mn
Jun 30, 2022 -7.72 Mn
Mar 31, 2022 -9.49 Mn
Dec 31, 2021 -12.51 Mn
Sep 30, 2021 -202,353.00
Jun 30, 2021 14.02 Mn